{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:16:45Z","timestamp":1792880205527,"version":"4.5.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,11]]},"DOI":"10.1097\/qad.0b013e3282f33557","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T04:33:45Z","timestamp":1236227625000},"page":"227-236","source":"Crossref","is-referenced-by-count":68,"title":["Zidovudine\/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy"],"prefix":"10.1097","volume":"22","author":[{"given":"Regje ME","family":"Bl\u00fcmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit GA","family":"van Vonderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Sutinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"Hassink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Ackermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel A","family":"van Agtmael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannele","family":"Yki-Jarvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven A","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans P","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection","volume":"40","author":"Bacchetti","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.2337\/diabetes.51.11.3163","article-title":"Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy","volume":"51","author":"Gan","year":"2002","journal-title":"Diabetes"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/eje.1.01835","article-title":"Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells","volume":"152","author":"Haugaard","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/00002030-200111090-00004","article-title":"Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"key":"R7-8-20210130","first-page":"225","article-title":"Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART)","volume":"25","author":"Vigouroux","year":"1999","journal-title":"Diabetes Metab"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"key":"R9-8-20210130","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"R10-8-20210130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00042560-200106010-00006","article-title":"Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients","volume":"27","author":"Dube","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-8-20210130","doi-asserted-by":"crossref","first-page":"55147","DOI":"10.1074\/jbc.M410826200","article-title":"A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity","volume":"279","author":"Hertel","year":"2004","journal-title":"J Biol Chem"},{"key":"R12-8-20210130","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.51.4.937","article-title":"Indinavir induces acute and reversible peripheral insulin resistance in rats","volume":"51","author":"Hruz","year":"2002","journal-title":"Diabetes"},{"key":"R13-8-20210130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/505974","article-title":"Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers","volume":"43","author":"Lee","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R14-8-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042560-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-8-20210130","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem"},{"key":"R16-8-20210130","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"R17-8-20210130","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study","volume":"16","author":"Noor","year":"2002","journal-title":"AIDS"},{"key":"R18-8-20210130","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavir\/ritonavir on insulin sensitivity in HIV-seronegative healthy adults","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"R19-8-20210130","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1097\/00002030-200409030-00017","article-title":"Indinavir increases glucose production in healthy HIV-negative men","volume":"18","author":"Schwarz","year":"2004","journal-title":"AIDS"},{"key":"R20-8-20210130","first-page":"383","article-title":"Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease","volume":"25","author":"Vigouroux","year":"1999","journal-title":"Diabetes Metab"},{"key":"R21-8-20210130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-127-10-199711150-00016","article-title":"Severe diabetes associated with protease inhibitor therapy","volume":"127","author":"Visnegarwala","year":"1997","journal-title":"Ann Intern Med"},{"key":"R22-8-20210130","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/diabetes.52.4.918","article-title":"Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens","volume":"52","author":"Woerle","year":"2003","journal-title":"Diabetes"},{"key":"R23-8-20210130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.qai.0000176654.97392.c7","article-title":"Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal","volume":"40","author":"Yan","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-8-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"R25-8-20210130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ajcn\/76.2.460","article-title":"Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men","volume":"76","author":"Meininger","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"R26-8-20210130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.aids.0000181011.62385.91","article-title":"Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study","volume":"19","author":"Brown","year":"2005","journal-title":"AIDS"},{"key":"R27-8-20210130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.qai.0000143599.64234.15","article-title":"Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine","volume":"38","author":"Shlay","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"R28-8-20210130","first-page":"E16","article-title":"Use of a variable tracer infusion method to determine glucose turnover in humans","volume":"258","author":"Molina","year":"1990","journal-title":"Am J Physiol"},{"issue":"4","key":"R29-8-20210130","first-page":"E531","article-title":"Hepatic glucose output in humans measured with labeled glucose to reduce negative errors","volume":"257","author":"Levy","year":"1989","journal-title":"Am J Physiol"},{"key":"R30-8-20210130","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1210\/jc.2004-1041","article-title":"A low-carbohydrate\/high-fat diet improves glucoregulation in type 2 diabetes mellitus by reducing postabsorptive glycogenolysis","volume":"89","author":"Allick","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-8-20210130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2006-1518","article-title":"Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance","volume":"92","author":"Serlie","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-8-20210130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/abio.1997.2535","article-title":"Determination of glycerol concentrations and glycerol isotopic enrichments in human plasma by gas chromatography\/mass spectrometry","volume":"258","author":"Ackermans","year":"1998","journal-title":"Anal Biochem"},{"key":"R33-8-20210130","first-page":"2220","article-title":"The quantification of gluconeogenesis in healthy men by (2)H2O and [2-(13)C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-(13)C]glycerol","volume":"86","author":"Ackermans","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-8-20210130","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1210\/jc.2002-020892","article-title":"Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure","volume":"87","author":"van der Valk","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-8-20210130","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1053\/meta.2002.34704","article-title":"Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy","volume":"51","author":"Hadigan","year":"2002","journal-title":"Metabolism"},{"key":"R36-8-20210130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00002030-200403050-00008","article-title":"The metabolic effects of lopinavir\/ritonavir in HIV-negative men","volume":"18","author":"Lee","year":"2004","journal-title":"AIDS"},{"key":"R37-8-20210130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R38-8-20210130","doi-asserted-by":"crossref","first-page":"E1666","DOI":"10.1152\/ajpendo.00550.2006","article-title":"Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults","volume":"292","author":"Fleischman","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R39-8-20210130","first-page":"34","article-title":"The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome","volume":"9","author":"Nolan","year":"2004","journal-title":"J HIV Ther"},{"key":"R40-8-20210130","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/01.aids.0000183629.20041.bb","article-title":"Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides","volume":"19","author":"Dube","year":"2005","journal-title":"AIDS"},{"key":"R41-8-20210130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"R42-8-20210130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/135965350400900607","article-title":"Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro","volume":"9","author":"Lagathu","year":"2004","journal-title":"Antivir Ther"},{"key":"R43-8-20210130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.beem.2005.07.003","article-title":"Fatty acids and insulin resistance in muscle and liver","volume":"19","author":"Kovacs","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R44-8-20210130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1126\/science.1104343","article-title":"Mitochondrial dysfunction and type 2 diabetes","volume":"307","author":"Lowell","year":"2005","journal-title":"Science"},{"key":"R45-8-20210130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ajcn\/77.2.490","article-title":"Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution","volume":"77","author":"Hadigan","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"R46-8-20210130","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1097\/00002030-200411050-00004","article-title":"The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro","volume":"18","author":"Caron","year":"2004","journal-title":"AIDS"},{"key":"R47-8-20210130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00002030-200403260-00015","article-title":"Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6\u201312 months of commencing nucleoside reverse transcriptase inhibitor therapy","volume":"18","author":"Hammond","year":"2004","journal-title":"AIDS"},{"key":"R48-8-20210130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1464-2662.2001.00073.x","article-title":"NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: fact or fiction?","volume":"2","author":"Walker","year":"2001","journal-title":"HIV Med"},{"key":"R49-8-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350601100109","article-title":"Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions","volume":"11","author":"Walker","year":"2006","journal-title":"Antivir Ther"},{"key":"R50-8-20210130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00125-006-0165-z","article-title":"Mitochondrial dysfunction in adipocytes: the culprit in type 2 diabetes?","volume":"49","author":"Maassen","year":"2006","journal-title":"Diabetologia"},{"key":"R51-8-20210130","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1086\/382531","article-title":"Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir\u2013ritonavir","volume":"38","author":"Martinez","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R52-8-20210130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jinf.2004.01.014","article-title":"Lopinavir\/ritonavir combination and total\/HDL cholesterol ratio","volume":"50","author":"Valerio","year":"2005","journal-title":"J Infect"},{"key":"R53-8-20210130","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1097\/00002030-200112070-00008","article-title":"Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an antiatherogenic lipid profile","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"key":"R54-8-20210130","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1371\/journal.pmed.0010019","article-title":"Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1","volume":"1","author":"van Leth","year":"2004","journal-title":"PLoS Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200801110-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:08:35Z","timestamp":1738976915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200801110-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,11]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282f33557","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,11]]}}}